510(k) Report

510(k) · Cleared

Cleared

Skin Dose Monitor

K961105510(k) TraditionalCleared Sep 5, 1996169-day reviewClass II21 CFR 892.1650

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Mcmahon Medical · OWB Interventional Fluoroscopic X-Ray System

Cleared on Sep 5, 1996 after a 169-day review. The FDA summary names its predicate without a number. 1 later device descends from it.

Decided
Sep 5, 1996
Review
169 days
Class
Class II
Product code
OWB
Recalls
None
Predicates
0

1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 2004: 1 descendant cleared1995200020052010201520202025
  1. This deviceK961105 Skin Dose MonitorMcmahon Medical · 1996
  2. Descendant · cites it directly · 0 of its ownK042698 Unfors Patient Skin Dosimeter (PSD)Unfors, Inc. · 2004

Most influential descendants

Showing 1 of 1 · See all
  • K042698Unfors Patient Skin Dosimeter (PSD)Unfors, Inc. · 2004 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K961105Skin Dose MonitorMcmahon Medical1996—
+1K042698Unfors Patient Skin Dosimeter (PSD)Unfors, Inc.2004—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200410
FIG. 1 — Lineage of K961105, 1996–2004Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OWB? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OWB device

  1. #1 K251602 Alphenix, INFX-8000V/B, INFX-8000V/S, V9.6…score 18.3 · 18 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—In Vivo Dosimeter
Named without a submission number
—

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K042698Unfors Patient Skin Dosimeter (PSD)Unfors, Inc.20040

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K042698 (Unfors, Inc., 2004) has gone furthest, with 0 descendants of its own.

How does its category compare?

All OWB devices

OWB Interventional Fluoroscopic X-Ray System: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · OWB

22in 2025

2007: 32008: 42009: 92010: 72011: 62012: 62013: 112014: 152015: 112016: 162017: 202018: 232019: 92020: 162021: 242022: 212023: 122024: 132025: 222026 (partial year): 15
2007high 24 (2021) · low 3 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OWB

148in 2025

2007: 52 days median2008: 135 days median2009: 99 days median2010: 66 days median2011: 79 days median2012: 37 days median2013: 119 days median2014: 158 days median2015: 66 days median2016: 103 days median2017: 76 days median2018: 54 days median2019: 174 days median2020: 53 days median2021: 60 days median2022: 90 days median2023: 152 days median2024: 126 days median2025: 148 days median2026 (partial year): 221 days median
2007high 221 (2026) · low 37 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · OWB

42so far in 2026, the most since 2007

2008: 12013: 102014: 92015: 352016: 132017: 132018: 62019: 72020: 82021: 312022: 242023: 222024: 112025: 302026 (partial year): 42
2007high 42 (2026) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · OWB

14,008in 2025

2007: 12011: 12012: 12013: 272014: 1032015: 2,1342016: 4,0742017: 1,6042018: 1,4492019: 1,5582020: 1,5812021: 1,9812022: 2,9322023: 7,6042024: 7,9422025: 14,008
2007high 14,008 (2025) · low 0 (2008)2025

MAUDE reports naming product code OWB, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200735201
2008413510
200999900
201076600
201167901
201263701
2013111191027
2014151589103
20151166352,134
201616103134,074
20172076131,604
2018235461,449
2019917471,558
2020165381,581
20212460311,981
20222190242,932
202312152227,604
202413126117,942
2025221483014,008
20261522142—

What is it indicated for?

Although intended primarily for use during Radiological Interventional and Special Procedures, the Skin Dose Monitor can be used whenever there is an interest in knowing patient skin‘dose. The primary purpose of the product is to monitor beam entry skin dose within the radiation beam, where there may be a risk of skin burns or cancers du~ to extremely high doses. In these situations the beam direction is fixed for a major part of the procedure and the…

Read the full statement (273 words)

Although intended primarily for use during Radiological Interventional and Special Procedures, the Skin Dose Monitor can be used whenever there is an interest in knowing patient skin‘dose. The primary purpose of the product is to monitor beam entry skin dose within the radiation beam, where there may be a risk of skin burns or cancers du~ to extremely high doses.

In these situations the beam direction is fixed for a major part of the procedure and the sensor siting is obvious.

If the Skin Dose Monitor is to be used for other applications such as dose monitoring of a pregnant woman during general radiological procedures or monitoring doses during fluoroscopic guided surgery, the sensor site may be less obvious. Under these circumstances the sensor might be mounted on the X-Ray collimator face.

The real time display of dose may be used to indicate the need to take action to avoid excessive dose to one area of skin by changing the beam direction. The rate indicating LED provides a means to take action which will keep dosage per minute during fluoroscopy at the minimum level needed to ensure acceptable images.

The Skin Dose Monitor is also an effective tool for use during staff training or when benchmark protocols are being established for new procedures.

Contra indications for use are when the radiation energy or doserate being used fall outside the Skin Dose Monitor's specification, or where the small artefact ¢ "he image (1 sq. mm), due to the sensor, is unacceptable.

‘. attention is drawn to the user for the need to gas sterilize sensors between applications in accordance with local infection control practice.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K961105: Skin Dose Monitor.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K961105

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026